These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 3094144)
1. Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice. Lanar DE; Pearce EJ; James SL; Sher A Science; 1986 Oct; 234(4776):593-6. PubMed ID: 3094144 [TBL] [Abstract][Full Text] [Related]
2. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen. Pearce EJ; James SL; Hieny S; Lanar DE; Sher A Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5678-82. PubMed ID: 3135553 [TBL] [Abstract][Full Text] [Related]
3. Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin. Flanigan TP; King CH; Lett RR; Nanduri J; Mahmoud AA J Clin Invest; 1989 Mar; 83(3):1010-4. PubMed ID: 2493482 [TBL] [Abstract][Full Text] [Related]
4. Paramyosin is the Schistosoma mansoni (Trematoda) homologue of antigen B from Taenia solium (Cestoda). Laclette JP; Landa A; Arcos L; Willms K; Davis AE; Shoemaker CB Mol Biochem Parasitol; 1991 Feb; 44(2):287-95. PubMed ID: 2052029 [TBL] [Abstract][Full Text] [Related]
5. Schistosoma mansoni gene GP22 encodes the tegumental antigen sm25: (1) antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine. Petzke MM; Suri PK; Bungiro R; Goldberg M; Taylor SF; Ranji S; Taylor H; McCray JW; Knopf PM Parasite Immunol; 2000 Aug; 22(8):381-95. PubMed ID: 10972845 [TBL] [Abstract][Full Text] [Related]
9. Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells. Fonseca CT; Cunha-Neto E; Kalil J; Jesus AR; Correa-Oliveira R; Carvalho EM; Oliveira SC Mem Inst Oswaldo Cruz; 2004; 99(5 Suppl 1):63-6. PubMed ID: 15486637 [TBL] [Abstract][Full Text] [Related]
10. Candidate vaccine antigens identified by antibodies from mice vaccinated with 15- or 50-kilorad-irradiated cercariae of Schistosoma mansoni. Richter D; Harn DA Infect Immun; 1993 Jan; 61(1):146-54. PubMed ID: 8418037 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection. Leow CY; Willis C; Leow CH; Hofmann A; Jones M Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972 [TBL] [Abstract][Full Text] [Related]
12. Induction of protective immunity against Schistosoma mansoni by a non-living vaccine. VI. Antigen recognition by non-responder mouse strains. James SL; Salzman C; Pearce EJ Parasite Immunol; 1988 Jan; 10(1):71-83. PubMed ID: 3127798 [TBL] [Abstract][Full Text] [Related]
13. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis. James SL; Pearce EJ J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608 [TBL] [Abstract][Full Text] [Related]
16. A lambda gt11 cDNA recombinant that encodes Dirofilaria immitis paramyosin. Grandea AG; Tuyen LK; Asikin N; Davis TB; Philipp M; Cohen C; McReynolds LA Mol Biochem Parasitol; 1989 Jun; 35(1):31-41. PubMed ID: 2527335 [TBL] [Abstract][Full Text] [Related]
17. Identification of paramyosin as a potential protective antigen against Brugia malayi infection in jirds. Li BW; Chandrashekar R; Alvarez RM; Liftis F; Weil GJ Mol Biochem Parasitol; 1991 Dec; 49(2):315-23. PubMed ID: 1775173 [TBL] [Abstract][Full Text] [Related]
18. Immunochemical characterization and purification of Sm-97, a Schistosoma mansoni antigen monospecifically recognized by antibodies from mice protectively immunized with a nonliving vaccine. Pearce EJ; James SL; Dalton J; Barrall A; Ramos C; Strand M; Sher A J Immunol; 1986 Dec; 137(11):3593-600. PubMed ID: 2431037 [TBL] [Abstract][Full Text] [Related]
19. Prospects for a nonliving vaccine against schistosomiasis based on cell-mediated immune resistance mechanisms. James SL; Pearce EJ; Sher A Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():121-3. PubMed ID: 3151085 [TBL] [Abstract][Full Text] [Related]
20. Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni. Marques HH; Zouain CS; Torres CB; Oliveira JS; Alves JB; Goes AM Immunobiology; 2008; 213(5):437-46. PubMed ID: 18472052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]